A Controlled Trial of Two Acellular Vaccines and One Whole-Cell Vaccine against Pertussis - Wikidata - awgldk - TriplyDB

A Controlled Trial of Two Acellular Vaccines and One Whole-Cell Vaccine against Pertussis

A Controlled Trial of Two Acellular Vaccines and One Whole-Cell Vaccine against Pertussis

http://www.wikidata.org/entity/Q56688401

about

Acellular vaccines for preventing whooping cough in children Acellular vaccines for preventing whooping cough in children Acellular vaccines for preventing whooping cough in children Acellular vaccines for preventing whooping cough in children Molecular pathogenesis, epidemiology, and clinical manifestations of respiratory infections due to Bordetella pertussis and other Bordetella subspecies.Rediscovering Pertussis Roads to the development of improved pertussis vaccines paved by immunology Pertussis vaccine trials in the 1990s Directed evaluation of enterotoxigenic Escherichia coli autotransporter proteins as putative vaccine candidates.Pertussis: Microbiology, Disease, Treatment, and Prevention.Molecular characterization of two Bordetella bronchiseptica strains isolated from children with coughs How to make sense of pertussis immunogenicity data.Production and characterization of recombinant pertactin, fimbriae 2 and fimbriae 3 from Bordetella pertussis.Recombinant Mycobacterium bovis BCG expressing pertussis toxin subunit S1 induces protection against an intracerebral challenge with live Bordetella pertussis in mice.Acellular pertussis vaccine efficacy: An updated systematic review and meta -analysis.Bordetella parapertussis infection in children: epidemiology, clinical symptoms, and molecular characteristics of isolates Acellular pertussis vaccine protects against exacerbation of allergic asthma due to Bordetella pertussis in a murine model.Above all, do no harm: assessing the risk of an adverse reaction.Haemophilus ducreyi secretes a filamentous hemagglutinin-like protein.A murine model in which protection correlates with pertussis vaccine efficacy in children reveals complementary roles for humoral and cell-mediated immunity in protection against Bordetella pertussis.Polymorphism in the Bordetella pertussis virulence factors P.69/pertactin and pertussis toxin in The Netherlands: temporal trends and evidence for vaccine-driven evolution Bordetella pertussis filamentous hemagglutinin enhances the immunogenicity of liposome-delivered antigen administered intranasally.Cytokine mRNA expression and proliferative responses induced by pertussis toxin, filamentous hemagglutinin, and pertactin of Bordetella pertussis in the peripheral blood mononuclear cells of infected and immunized schoolchildren and adults Differential effect of TLR2 and TLR4 on the immune response after immunization with a vaccine against Neisseria meningitidis or Bordetella pertussis.Th17 cytokines and vaccine-induced immunity.Toxic shock syndrome toxin-1-mediated toxicity inhibited by neutralizing antibodies late in the course of continual in vivo and in vitro exposure.Diagnosis and management of pertussis.Shifts of Bordetella pertussis variants in Sweden from 1970 to 2003, during three periods marked by different vaccination programs Analysis of Bordetella pertussis populations in European countries with different vaccination policies Protective effects of pertussis immunoglobulin (P-IGIV) in the aerosol challenge model Development of a recombinant epsilon toxoid vaccine against enterotoxemia and its use as a combination vaccine with live attenuated sheep pox virus against enterotoxemia and sheep pox.Comparison of five commercial enzyme-linked immunosorbent assays for detection of antibodies to Bordetella pertussis Humoral and cellular immune responses in mice immunized with recombinant Mycobacterium bovis Bacillus Calmette-Guérin producing a pertussis toxin-tetanus toxin hybrid protein.Acellular pertussis vaccines and the role of pertactin and fimbriae.Mutants of Escherichia coli heat-labile toxin act as effective mucosal adjuvants for nasal delivery of an acellular pertussis vaccine: differential effects of the nontoxic AB complex and enzyme activity on Th1 and Th2 cells.A regulatory role for interleukin 4 in differential inflammatory responses in the lung following infection of mice primed with Th1- or Th2-inducing pertussis vaccines.Whole-cell but not acellular pertussis vaccines induce convulsive activity in mice: evidence of a role for toxin-induced interleukin-1beta in a new murine model for analysis of neuronal side effects of vaccination.Long-term pertussis-specific immunity after primary vaccination with a combined diphtheria, tetanus, tricomponent acellular pertussis, and hepatitis B vaccine in comparison with that after natural infection.Evidence of Bordetella pertussis infection in vaccinated 1-year-old Danish children.Update on pertussis in children.

P2860

Q24193554-4A19A4E7-5C62-4E11-B9A9-C0E6E9886F2E Q24201103-8918077C-901E-43AC-827D-D568E57E934F Q24234899-6CFBD520-0CBD-4B6D-9C6C-243E9F9C83BB Q24243261-78D47058-7E2C-41C9-B22E-56AD2B484AB4 Q24522458-439D4A05-EB2E-4899-ACF7-B1AF0C1F2F4B Q26744793-920A975B-4E35-4C2D-B94A-D06F7B563E8E Q26782939-2D458447-A39B-4BEB-A5BA-3CD9112D85EF Q27025393-0A128891-12A6-40D5-A278-7D31AA2C87F7 Q30155406-4ECA14D9-699E-4322-BBF5-8D6BA2B414A0 Q30251684-A0C0BD32-8011-4A63-A231-FB089D07D499 Q30452542-D66D7CC4-9473-40F5-B6A8-914EE15622FD Q30665598-7AE3AEBE-F852-425B-872E-FDF6AEB62694 Q33521111-A99344B1-F232-4B7B-99FD-7BEB0627713B Q33596979-971098E4-7173-4176-A0A8-953635099064 Q33642326-13E8DC56-5421-4E80-9EC8-E69B49286610 Q33661613-ACD0B7EB-2CF0-4336-A522-69FF7C7704C0 Q33716587-543EB52A-387F-4416-8792-D15D50B1C520 Q33728888-9DC3A8DB-B5D0-496B-80A1-3787EB643E96 Q33741949-3CC9E6EC-95D6-4624-A242-19BD7DB8A6C0 Q33750257-D3E781E6-4755-4E57-B4FA-9AC96E68AD0B Q33750402-F2DF2D66-A709-4620-B500-757E638CD100 Q33752750-BB74DF6D-60BD-4F60-A2D3-3D612FDF8A93 Q33758073-C13CAC63-5C15-452C-8E6F-35DA6ADADAA7 Q33784386-5334D5D0-B255-4AF8-A1BB-FDED945FDFD8 Q33792227-49A10906-F9D3-45AD-A114-0E9F1001066F Q33813616-0CAAFCB9-AB74-432C-A7CA-2B426DE72CDE Q33833442-1DEE07BF-E9BA-4A87-804A-805D37ECBB23 Q33856133-100B68A5-AD56-486F-BAFA-0F7782A76784 Q33856228-0D8C20F1-5F2F-4B04-9217-49A2CD65A1B2 Q33866775-E8DA4790-0C11-42A4-84D1-3DB84006623A Q33909152-A0F05089-F587-4AC1-BEB2-50771ED0A0CA Q33998364-D2A15047-0E8A-49EB-900E-EA79D5FB5AD7 Q34002019-0C930EE5-A1F6-4608-8D70-E2B6CA716D48 Q34002283-B3BF4451-CC7A-41B9-ADC5-923A0DBF554E Q34002672-25C95577-9446-4C64-B5AB-FF63C6E0C397 Q34003563-701861D6-167B-4B1E-9B9F-F8387F704B74 Q34008022-E966D2A7-B559-4F05-B791-D5B5F0EFCEC8 Q34008317-E81DEE02-8674-4C57-AD6A-C46FCC2A7A1A Q34013394-9795CF8F-3C0E-4931-8C3B-2E66E36BD83B Q34095301-E4B3306F-952F-452B-AD27-725D243D848F

P2860

A Controlled Trial of Two Acellular Vaccines and One Whole-Cell Vaccine against Pertussis

http://www.wikidata.org/entity/Q56688401

description

article

@en

im Februar 1996 veröffentlichter wissenschaftlicher Artikel

@de

wetenschappelijk artikel

@nl

наукова стаття, опублікована в лютому 1996

@uk

ലേഖനം

@ml

name

A Controlled Trial of Two Acellular Vaccines and One Whole-Cell Vaccine against Pertussis

@en

A Controlled Trial of Two Acellular Vaccines and One Whole-Cell Vaccine against Pertussis

@nl

type

label

A Controlled Trial of Two Acellular Vaccines and One Whole-Cell Vaccine against Pertussis

@en

A Controlled Trial of Two Acellular Vaccines and One Whole-Cell Vaccine against Pertussis

@nl

prefLabel

A Controlled Trial of Two Acellular Vaccines and One Whole-Cell Vaccine against Pertussis

@en

A Controlled Trial of Two Acellular Vaccines and One Whole-Cell Vaccine against Pertussis

@nl

P1433

Q56688401-D0B66A61-CB6F-4C5D-83A9-1AC6402B71C2

P1476

Q56688401-6FE35599-2420-4FDD-A793-DCAAABE49359

P2093

Q56688401-10E134FB-E8A3-4E0E-8216-25461BCA8451

Q56688401-2B8F8A8E-EAB8-4D93-A3B1-9E92AC838A87

Q56688401-5E21C68C-F8F7-434C-8D24-4ACB054ACB20

Q56688401-714CFE06-DFAD-4DDB-967F-D78343B2D5B2

Q56688401-7271A9ED-EBB0-4632-8DB2-0B3D83AE3D38

Q56688401-7BC5BFF8-3B72-46FC-84EE-C1CFE8A3B7D6

Q56688401-8281B754-D4DA-4FC1-9CBE-6B20F682DC1C

Q56688401-987582B7-EEF3-438D-BCA3-8BDDF8B5E53D

Q56688401-CF2059BD-6758-4228-9E75-91CEB3D18712

Q56688401-E2CB9BF7-3EF4-4698-B320-1A1157705E6A

P304

Q56688401-DBFC0FE9-C634-4959-A96D-1BC5A8699D91

P31

Q56688401-E27B6388-F2DB-4080-8465-7F4D4E95D86B

P356

Q56688401-9DB90106-0CC9-4A7B-A963-72B63A32EF19

P407

Q56688401-7100DEE4-9BCA-477C-96DA-468D43A127EA

P433

Q56688401-04F4CAAA-79F0-47DD-A9E6-8A1501145A94

P478

Q56688401-D3ACEE39-33E9-42A8-9276-4BAD67D79966

P50

Q56688401-15112EF0-809E-4AB7-9F6A-08AFEAB68D02

Q56688401-2204312D-3CA3-4D89-B080-5DBAF5D9B24F

P577

Q56688401-09B22EAC-7888-42F5-BA55-D67BD178A19C

P698

Q56688401-C1FDFF2D-06D9-4F3D-BB35-65795EDB8ED3

P356

NEJM199602083340601

P1433

The New England Journal of Medicine

P1476

A Controlled Trial of Two Acellular Vaccines and One Whole-Cell Vaccine against Pertussis

@en

P2093

Alessandra Anemona

http://www.w3.org/2001/XMLSchema#string

Anna Giammanco

http://www.w3.org/2001/XMLSchema#string

David L. Klein

http://www.w3.org/2001/XMLSchema#string

Donato Greco

http://www.w3.org/2001/XMLSchema#string

Marta L. Ciofi degli Atti

http://www.w3.org/2001/XMLSchema#string

Paola Mastrantonio

http://www.w3.org/2001/XMLSchema#string

Pietro Panei

http://www.w3.org/2001/XMLSchema#string

Stefania Salmaso

http://www.w3.org/2001/XMLSchema#string

Steven G.F. Wassilak

http://www.w3.org/2001/XMLSchema#string

William C. Blackwelder

http://www.w3.org/2001/XMLSchema#string

P304

341-349

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1056/NEJM199602083340601

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

334

http://www.w3.org/2001/XMLSchema#string

P50

Alberto E. Tozzi

Marina Giuliano

P577

1996-02-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

8538704

http://www.w3.org/2001/XMLSchema#string